![Canada's CPHO on X: "2/3 A: Yes. ➡️Moderna and Pfizer mRNA vaccines are considered interchangeable. ➡️If you had AstraZeneca for your first dose, you'll likely be offered one of the mRNA vaccines Canada's CPHO on X: "2/3 A: Yes. ➡️Moderna and Pfizer mRNA vaccines are considered interchangeable. ➡️If you had AstraZeneca for your first dose, you'll likely be offered one of the mRNA vaccines](https://pbs.twimg.com/media/E5TnLCoX0BA3I9I.jpg)
Canada's CPHO on X: "2/3 A: Yes. ➡️Moderna and Pfizer mRNA vaccines are considered interchangeable. ➡️If you had AstraZeneca for your first dose, you'll likely be offered one of the mRNA vaccines
![Miocarditi, pericarditi e vaccino a mRNA contro il COVID-19. Expert opinion della Società Italiana di Cardiologia | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana Miocarditi, pericarditi e vaccino a mRNA contro il COVID-19. Expert opinion della Società Italiana di Cardiologia | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana](https://www.giornaledicardiologia.it/allegati/03689_2021_11/images/gic_2111_21.jpg)
Miocarditi, pericarditi e vaccino a mRNA contro il COVID-19. Expert opinion della Società Italiana di Cardiologia | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana
![Did you get AZ for your first dose? Moderna as good as Pfizer for second shot, experts say | CTV News Did you get AZ for your first dose? Moderna as good as Pfizer for second shot, experts say | CTV News](https://www.ctvnews.ca/content/dam/ctvnews/en/images/2021/2/25/moderna-1-5325038-1627383753460.jpg)
Did you get AZ for your first dose? Moderna as good as Pfizer for second shot, experts say | CTV News
![COVID-19 Update: Bivalent Pfizer and Moderna COVID-19 Vaccines for Booster Immunization | The Medical Letter Inc. COVID-19 Update: Bivalent Pfizer and Moderna COVID-19 Vaccines for Booster Immunization | The Medical Letter Inc.](https://secure.medicalletter.org/images/TML1660c-1.png)
COVID-19 Update: Bivalent Pfizer and Moderna COVID-19 Vaccines for Booster Immunization | The Medical Letter Inc.
![Esclusiva Report: ecco i contratti "segreti" di Pfizer e Moderna per i vaccini anti-Covid - Report - Rai Esclusiva Report: ecco i contratti "segreti" di Pfizer e Moderna per i vaccini anti-Covid - Report - Rai](https://www.rai.it/resizegd/-x540/dl/img/2021/04/17/1618676627243_Progetto%20senza%20titolo.jpg)
Esclusiva Report: ecco i contratti "segreti" di Pfizer e Moderna per i vaccini anti-Covid - Report - Rai
![Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system - eClinicalMedicine Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system - eClinicalMedicine](https://www.thelancet.com/cms/asset/2e79c946-a76f-459d-8e49-c3f1fef08276/gr1.jpg)
Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system - eClinicalMedicine
![Vaccini, via libera dell'Ema a quello di Moderna. In Italia inoculate oltre 303mila dosi del prodotto Pfizer-BioNtech - la Repubblica Vaccini, via libera dell'Ema a quello di Moderna. In Italia inoculate oltre 303mila dosi del prodotto Pfizer-BioNtech - la Repubblica](https://www.repstatic.it/content/nazionale/img/2021/01/06/214544530-984d739d-d7f9-438f-9a79-415f90516838.jpg)
Vaccini, via libera dell'Ema a quello di Moderna. In Italia inoculate oltre 303mila dosi del prodotto Pfizer-BioNtech - la Repubblica
![Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021 | MMWR Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/figures/mm7049a2-F.gif?_=85790)
Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021 | MMWR
![Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7020e2_EffectivenessPfizerModernaHCP_IMAGE_14May21_1200x627.jpg?_=36679)
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR
![Vaccini, "Pfizer, Biontech e Moderna guadagnano 1.000 dollari al secondo, ma nei Paesi a basso reddito è immunizzato solo il 2% delle persone - la Repubblica Vaccini, "Pfizer, Biontech e Moderna guadagnano 1.000 dollari al secondo, ma nei Paesi a basso reddito è immunizzato solo il 2% delle persone - la Repubblica](https://www.repstatic.it/content/nazionale/img/2021/11/16/164352054-5a460c23-9f93-497b-b6a7-4c7326a9f351.jpg)
Vaccini, "Pfizer, Biontech e Moderna guadagnano 1.000 dollari al secondo, ma nei Paesi a basso reddito è immunizzato solo il 2% delle persone - la Repubblica
![PFIZER/BIONTECH E MODERNA GUADAGNANO 1.000 DOLLARI AL SECONDO, MA NEI PAESI POVERI È VACCINATO IL 2% DELLA POPOLAZIONE - Oxfam Italia PFIZER/BIONTECH E MODERNA GUADAGNANO 1.000 DOLLARI AL SECONDO, MA NEI PAESI POVERI È VACCINATO IL 2% DELLA POPOLAZIONE - Oxfam Italia](https://www.oxfamitalia.org/wp-content/uploads/2021/11/OxfamIndia@cure-mediche-alla-popolazione-coronavirus-1-1.jpg)